CYTOMX THERAPEUTICS INC. - COMMON STOCK
2.5200
29-May-25 13:45:00
15 minutes delayed
Stocks
+0.1200
+5.00%
Today's range
2.3800 - 2.5850
ISIN
N/A
Source
NASDAQ
-
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
04 Mar 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming March Investor Conferences
27 Feb 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
12 Jan 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Outlines 2024 Company Priorities and Milestones
04 Jan 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
21 Dec 2023 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
07 Nov 2023 13:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
01 Nov 2023 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023
31 Oct 2023 05:00:00 By Nasdaq GlobeNewswire
-
30 Oct 2023 05:00:00 By Nasdaq GlobeNewswire
-
18 Oct 2023 13:30:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming September Investor Conferences
05 Sep 2023 13:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
10 Aug 2023 13:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
08 Aug 2023 13:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023
01 Aug 2023 05:00:02 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
20 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Appoints Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer
17 Jul 2023 05:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.
30 Jun 2023 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the Jefferies Healthcare Conference
01 Jun 2023 13:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
09 May 2023 13:15:00 By Nasdaq GlobeNewswire